ID: ALA4588675

Max Phase: Preclinical

Molecular Formula: C28H37N9O5

Molecular Weight: 579.66

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  COC(=O)CNC(=O)[C@H](CCCCNC(C)=O)NC(=O)Cn1cc(CN(Cc2ccccn2)Cc2ccccn2)nn1

Standard InChI:  InChI=1S/C28H37N9O5/c1-21(38)29-12-8-5-11-25(28(41)32-15-27(40)42-2)33-26(39)20-37-19-24(34-35-37)18-36(16-22-9-3-6-13-30-22)17-23-10-4-7-14-31-23/h3-4,6-7,9-10,13-14,19,25H,5,8,11-12,15-18,20H2,1-2H3,(H,29,38)(H,32,41)(H,33,39)/t25-/m0/s1

Standard InChI Key:  KOYABOOTLSUPMJ-VWLOTQADSA-N

Associated Targets(non-human)

Beta-lactamase VIM-2 381 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Beta-lactamase NDM-1 246 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 579.66Molecular Weight (Monoisotopic): 579.2918AlogP: 0.35#Rotatable Bonds: 17
Polar Surface Area: 173.33Molecular Species: NEUTRALHBA: 11HBD: 3
#RO5 Violations: 2HBA (Lipinski): 14HBD (Lipinski): 3#RO5 Violations (Lipinski): 2
CX Acidic pKa: 11.67CX Basic pKa: 5.29CX LogP: -1.11CX LogD: -1.11
Aromatic Rings: 3Heavy Atoms: 42QED Weighted: 0.15Np Likeness Score: -1.29

References

1. Kildahl-Andersen G, Schnaars C, Prandina A, Radix S, Le Borgne M, Jordheim LP, Gjøen T, Andresen AMS, Lauksund S, Fröhlich C, Samuelsen Ø, Rongved P, Åstrand OAH..  (2019)  Synthesis and biological evaluation of zinc chelating compounds as metallo-β-lactamase inhibitors.,  10  (4): [PMID:31057732] [10.1039/C8MD00578H]

Source